2023 Poster Competition for Resident/Fellow and Medical Student Members at the IPS Annual Meeting
Submission period has ended
RFM and Medical Student Invitation:
The Illinois Psychiatric Society invites all Illinois psychiatric residents/fellows and medical students to submit an abstract for consideration for a judged poster presentation at the Illinois Psychiatric Society Annual Meeting, to be held in Oak Brook, IL on Saturday, October 7, 2023. Please review the Poster Guidelines for complete information regarding participation and prizes.
The submission deadline is midnight on August 31, 2023.
Accepted abstract authors will be invited to present a physical poster presentation. Poster presenters are asked to be available to present on Saturday, October 7, 2023. Resident-Fellow and Medical Student poster presenters will be juried by a panel and are required to be present for the judging session to be considered for a prize.
Prizes: Case posters and research posters will be judged separately with a first and second place winner in each category. A scholarship prize award of $250 for first place and $100 for second place will be awarded.
POSTER SUBMISSION AND PRESENTATION GUIDELINES:
Guidelines for Abstract Submission:
Posters are to present new research and case findings. There shall be only one presenter per virtual poster (see Guidelines below for permitted substitutions). An abstract relating to the poster content shall be submitted by the stated deadline. After review, the submitting author will be notified if accepted for in-person poster presentation and given information regarding the specifics of presenting. In additional to submitting the overall poster abstract (maximum of 300 words), which shall be a concise description of results, findings, and conclusions, the presenter shall submit (i) the poster title (ii) presenter information (name and credentials, affiliation, e-mail, and telephone), (iii) list all co-authors, separated only by commas (name and credentials, academic affiliation not required unless changed to be the substitute presenter.) All presenters must be available to present at the meeting and must register for the meeting prior to the date of their presentation.
Guidelines for Poster Session:
There may only be one presenter for each poster and the presenter must be included among the authors listed on the abstract submission. If the researcher or named first author who submitted the poster cannot attend the meeting and wishes to have a co-author substitute, please notify the IPS office (mengelbrecht@ilpsych.org). The substitute presenter must provide contact information and agree to the IPS Poster Guidelines, as well as be a member of IPS, in order to be included as the presenter at the meeting. The substitute presenter will be considered the named first author for purposes of peer judging and recognition.
Posters must report only findings of the research/case report. No advertising or product identification by brand name is allowed. If any or all of the work in this poster was prepared with commercial support, a statement “Supported by funding from [name of company]” must be noted in the lower left corner of the poster in clearly identifiable font, with no bold, italics, special colors, or other enhancement of the company name, product, or any other portions of the statement. Generic names of drugs should be used throughout the poster; if brand names must be used, they must be used for all products referenced. Information regarding unapproved uses of approved products or investigational uses of unapproved products must be clearly presented with the following statement included on the poster: “The following information concerns a use that has not been approved by the U.S. Food and Drug Administration.” The presenter must wear only their IPS meeting badge and not badges or insignia of companies. No company or product identification may be included on badges or otherwise worn by the presenter. If providing handouts, the handouts must be limited to one page. The handouts must include the disclosure information on the funding of the research: “The research reported here was supported by [name of company].” Generic names of drugs should be used throughout in the handout. Any information regarding unapproved uses of approved products or investigational uses of unapproved products must include the following statement: “The following information concerns a use that has not been approved by the U.S. Food and Drug Administration.”
The Poster Presentation:
PRINT DIMENSIONS: Maximum 3’ H X 4’ W
LAYOUT:
Headings for research posters should be: Abstract, Methods, Results, Discussion, References
Headings for case posters should be: Abstract, Background, Case, Discussion, References
Any charts or tables should be large enough to be legible to attendees.
POSTER SET UP: Saturday, October 7 at the Le Meridian Chicago – Oakbrook Center between the hours of 12:30 – 2:00 p.m.
POSTER JUDGING: For award eligibility, a poster author must be present with poster during the judging period to answer questions.
Guidelines for Poster Recognition:
Recognitions of the results of judging on the poster presentation will be made out to the named first author (the poster presenter). In the instance of a substitute presenter, he or she shall be considered to be the named first author for the sake of recognition. Prizes are awarded solely to the named first author (the poster presenter).
Posters will be available and judged during the afternoon prior to the awards dinner. Winning poster announcements and awards will take place at the awards dinner that evening.
Questions: If you have any questions, please email Kristen Malloy or Meghan Engelbrecht.